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SUMMARY
In this long term retrospective study of radiation synovectomy with Yttrium-90 (Y90), we evaluated the results of 164
applications in 82 patients with RA, OA with synovitis, ankylosing spondylitis and psoriatic arthritis. Radiation syn-
ovectomy with Y90 has an overall success rate of approximately 50% and is therefore an effective alternative to surgical
synovectomy in chronic synovitis which fails to respond to conservative treatment. Elbow and knee responded signifi-
cantly better than shoulder and ankle joints. Patients with radiological stages from 0 to 2 showed a significantly better suc-
cess rate than those with stage 3 changes. In responders, repeat therapy for recurrence of symptoms or treatment of a
symptomatic corresponding symmetrical joint is advisable. Repeat therapy in a previous non-responder is associated with
an unacceptably high failure rate. Therefore, when a joint fails to respond after 6 months, arthroscopy should be performed
to evaluate further treatment procedures. A successful result was found in only 11 of 25 joints treated with arthroscopic
synovectomy followed by radiation synovectomy within 2 weeks, indicating no benefit of this combination.
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CHRONIC synovitis, unresponsive to systemic medical
therapy including anti-inflammatory drugs and remis-
sion inducing agents and intra-articular administration
of corticosteroids, can be treated with synovectomy.
Since 1963, when Ansell and co-workers [1], based on
experience of radiation pleurodesis [2] reported the first
study of intra-articular radiocolloids in the treatment of
persistent knee effusion, radiation synovectomy has
been shown to be an effective alternative to surgical syn-
ovectomy without its risks [3] and to be an alternative to
chemical synovectomy with osmic acid [4].
In order to minimize the biological hazards, radioac-
tive gold was substituted with Yttrium-90 (Y90) [5-8].
Y90 has the advantage of being a pure beta-emitter,
having greater soft tissue penetration and a larger par-
ticle size with correspondingly much less accumulation
of Y90 in regional lymph nodes. Immobilization of the
treated limb was found to be another effective measure
reducing leakage to the regional lymph nodes [9].
The aim of our retrospective long term analysis of 164
radiation synovectomies was to evaluate the efficacy
and safety of radiation synovectomy with Y90 and to
determine which factors influence a successful outcome.
PATIENTS AND METHODS
Between 1979 and 1989 a total of 164 joints in 82
patients were treated with intra-articular injection of
Y90. There were 44 women and 38 men, with a mean age
of 40.5 years (range 20-77 years). The diagnoses and the
joints treated are shown in Table I. The mean duration of
the disease before therapy was 7.8 years. All patients
had active and persistent synovitis of the treated joint of
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more than 6 months duration refractory to anti-inflam-
matory medication disease-modifying drugs (patients
with RA) and intra-articular steroid therapy. Twenty-
five joints had undergone arthroscopic synovectomy
14-18 days before synovirothesis [10].
The doses of Y90 used in the study were 6 mCi for the
knee joint, 3 mCi for the shoulder and the hip and 2 mCi
for the ankle and the elbow [11]. Two days before the
synoviorthesis the effusion was tapped and 40 mg tri-
amcinoloneacetonide was injected. Y90 was injected
under local anaethesia after controlling for the correct
intra-articular position of the needle by contrast media
and image amplification. To prevent transient local
reaction and to clear the needle from the nuclide before
withdrawing the needle, a further injection of 40 mg tri-
amcinoloneacetonide was given. Imagingof activity dis-
tribution over the joint, the groin, the aortic lymph
nodes and the liver with a large field gamma-camera was
performed immediately, 24 and 48 h after intra-articular
injection of Y90 in 120 of the 164 joints treated with radi-
ation synovectomy. In order tominimizesystemicdistri-
bution of the radioactive agent the patients with
synoviorthesis of the lower limb were bed rested for 3
days after injection [9], patients with treatment of the
upper limb had to wear an arm sling. During the period
of bed rest, the patients were treated by a physiothera-
pist who performed an antithrombotic exercise pro-
gramme twice a day.
In retrospective clinical evaluation, results were
classified according to the patients subjective assess-
ment as excellent, good, fair or poor. Patients with an
excellent result had complete pain relief and no joint
effusion, patients with a good result had almost com-
plete relief of pain and little joint effusion for at least 1
year. Patients with a fair result had partial symptomatic
relief and a diminished joint swelling, patients with a
poor result had no benefit from the treatment resulting
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Diagnosis
Seropositive RA
Seronegative RA
Monarthritis
PsA
AS
Oligoarthritis
OA
Total
TABLE I
CLINICAL DIAGNOSIS AND JOINTS TREATED
No. of patients
40
14
5
8
3
1
11
82
Joints
105
22
5
8
5
2
17
164
Knee
57
15
4
3
5
2
17
103
Ankle
18
3
1
1
0
0
0
23
Shoulder
18
3
0
3
0
0
0
24
Elbow
9
1
0
1
0
0
0
11
Hip
3
0
0
0
0
0
0
3
in continued pain and swelling. Excellent and good were
considered as success, fair and poor as failure. Further-
more a clinical, laboratory and radiological evaluation
according to Larsen et al. [12] was performed to assess
clinical status and functional capacity.
RESULTS
Table II shows the overall results 1 year after radi-
ation synovectomy as stated by the patient at the time of
retrospective clinical evaluation. Improvement was
noted in 60% with a good or excellent result in 48%.
Therefore successful synoviorthesis was seen in 48%. A
marked difference was found depending on the joints
treated and depending on the underlying disease pro-
cess. Elbow and knee responded significantly better,
shoulder and ankle significantly less well (/><0.046,
Kruskal-Wallis analysis) (Fig. 1). Significantly better
results than in PsA were obtained in patients suffering
from AS (V<0.04, two-sample test) and OA (7><0.034).
The results for RA did not differ significantly from the
other groups and there was also no significant difference
between seronegative and seropositive RA (Fig. 2).
Figure 3 shows the percentage of RA patients pres-
enting with little or no pain or effusion (successes) at the
time of clinical evaluation as a function of the time since
the synoviorthesis. There was a marked decline in the
success rate at year 3 and up to 7 years after therapy we
found a persistent good or excellent result in about 20%
of cases.
Age was not a predictor of the result. In patients with
RA under the age of 55,30 successes and 34 failures were
noted, whereas over the age of 56, 30 successes and 33
failures were obtained revealing no difference.
Activity of the disease process at the time of clinical
evaluation (RA patients, 127 joints), measured by
patients self-assessment, Ritchie index and erythrocyte
sedimentation rate showed no significant difference
between the successes and failures in the two sample
tests. Because of the reported low response rate in
advanced radiological stages, radiation synovectomy in
stages 3 and 4 was performed only six and two times
respectively. We found a clearly better success rate in
patients with Larsen stage 0 (60.9%), 1 (61.5%) and 2
(33.3%) than 3 (16.7%) prior to therapy (P<0.097, two
sample test). In 75 cases of RA where a control X-ray
could be performed, 56 showed no progression whereas
a progression of one stage was seen in 11 and two stages
in eight applications.
A significant difference in the success rate between
patients with no limitation in range of motion, patients
with little and patients with marked functional limi-
tation at the time of clinical evaluation was found
(P<0.0003, Kruskal-Wallis analysis).
The 25 cases who had undergone arthroscopic syn-
ovectomy before radiation synovectomy showed a suc-
cess rate of 44% indicating no significant difference
compared to the joints without this treatment.
Fourteen joints underwent a second radiation syn-
ovectomy. In the five joints with a previous success
(responders) a constantly good outcome was achieved,
whereas in the nine cases with an initial failure, success
at the second attempt was only seen twice.
In 43 cases of a time parallel therapy of two different
joints (39 cases on symmetric joints) in the same patient,
the outcome differed in only four cases.
Imaging of activity distribution with a large field
gamma-camera showed a homogeneous activity distri-
bution in 111 cases, whereas only four had an irregular
TABLE II
SUCCESSES AND FAILURES 1 YEAR AFTER RADIATION SYNOVECTOMY AS STATED BY THE PATIENT AT THE TIME OF THE RETROSPECTIVE
CLINICAL EVALUATION. (First column: successes; second column: failures)
Diagnosis Knee Ankle Shoulder Elbow Success
Seropositive RA
Seronegative RA
Monarthritis
PsA
As
Oligoarthritis
OA
30
9
1
1
4
0
12
27
6
3
2
1
2
5
4
0
0
0
14
3
1
1
5
2
0
13
1
3
46
54.5
20
12.5
80
0
71
Success rate 55.3 29 17 82 48
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FIG. 1.—Results 9 months after radiation synovectomy as stated
by the patient for the knee, the ankle, the shoulder and the elbow
joint.
activity distribution: a hot spot was detected in three
cases and no intra-articular distribution at all was found
RA+ RA- AS PsA
FIG. 2.—Results 9 months after therapy as stated by the patient
for seropositive rheumatoid arthritis (RA+), seronegative RA
(RA-), osteoarthritis (OA), ankylosing spondylitis (AS) and
psoriatic arthritis (PsA).
in two cases. No radiation leakage over the groin, the
aortic lymph nodes and the liver was detected.
The success rate was 55% with regular distribution
but there was only one successful outcome in the four
cases with irregular distribution; of the three cases with a
hot spot two were successful and as expected the two
joints showing no intra-articular distribution were both
failures. No radiation-induced problems at the site of
injection or other important complications were
observed. There was no local or systemic malignancy
induction in the 82 patients controlled, which add up to
307 patient years. Fourteen of 62 knee joints controlled
by X-ray showed a subpatellar calcification; 12 of these
cases had a homogeneous intra-articular distribution in
the scintigraphic control whereas two showed a hot spot
[13].
DISCUSSION
Previous studies have demonstrated the efficacy of
radiation synovectomy with Y90 and the statistically sig-
nificant superiority of Y90 to saline, non-radioactive
yttrium and corticosteroids [14,15] in the treatment of
the large and medium sized joints in RA, PsA and OA
[16,18].
The results found in our study with an overall success
rate in 48% and excellent response rates in OA and AS
are similar to the response rates reported in the liter-
ature [16,19]. The high failure rate in the few patients
with PsA may have been influenced by the low response
rate of the treated joints (one ankle and three shoulder
joints).
There is a remarkable difference between the differ-
ent joints treated. Similar to Menkes etal. [16], we found
a high success rate in the treatment of the elbow and the
knee joint but poor results in the shoulder and ankle
joints. The poor result in the shoulder joint may be due
to the pathologically important involvement of the rota-
tor cuff usually present, which is not influenced by
synoviorthesis.
The question of a repeat therapy arises when a first
injection has shown a poor result or when there is recur-
rence of symptoms after an initial response. It is impor-
100
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FIG. 3.—Percentage of RA patients with little or no pain and
effusion (successes) at the time of clinical evaluation as a func-
tion of the time since radiation synovectomy (year groups). The
bars show the number of applications in each group.
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tant to note, that one can reasonably predict at 6 months
whether the treatment is going to succeed or fail [16] and
therefore plan a further injection or a surgical synovec-
tomy at that stage. We found it worthwhile repeating
injection in an initially respondingjoint, whereas in non-
responders the chance of success at the second attempt
is limited confirming the results of Winfield and Gumpel
[20]. In these cases an arthroscopic evaluation is advis-
able to investigate the cause of the failure and adapt
treatment accordingly. With severe cartilaginous
lesions, performing a second synoviorthesis would seem
worthless and operative measures such as prosthetic
surgery could be planned. In the case of fibrinonecrotic
deposits, found especially in severe fibrin-producing
hypertrophic synovitis, arthroscopy could be used to
wash out the deposits and to abrade the remaining syn-
ovial tufts [21]. If failure is due to technical reasons such
as lack of activity, revealed by a scintigraphic control,
the procedure can be repeated immediately.
Interestingly we found a high correlation in the treat-
ment of symmetric joints, making treatment of the
corresponding symptomatic joint favourable. A pre-
vious arthroscopic synovectomy to remove as much of
the proliferative synovium as possible in order to
improve the effect of the radionuclide on the remaining
synovium [10], was associated with a success rate of not
more than 44%. This moderate success rate differs to a
considerable extent from the excellent results reported
for arthroscopic synovectomy as a single procedure
[22-24] or after failure of radiation synovectomy [25].
Further studies are needed to evaluate arthroscopic syn-
ovectomy followed by radiation synovectomy com-
pared to radiation synovectomy or arthroscopic
synovectomy alone. The optimal time interval may be
longer than the 1 to 2 weeks reported in this study. In
addition the selection of patients for this combined pro-
cedure might be important.
In conclusion we can say, that radiation synovectomy
with Y90 is a safe and useful instrument in the thera-
peutic strategy for patients with RA, OA and AS.
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